Literature DB >> 24006330

A review of covariate selection for non-experimental comparative effectiveness research.

Brian C Sauer1, M Alan Brookhart, Jason Roy, Tyler VanderWeele.   

Abstract

This paper addresses strategies for selecting variables for adjustment in non-experimental comparative effectiveness research and uses causal graphs to illustrate the causal network that relates treatment to outcome. Variables in the causal network take on multiple structural forms. Adjustment for a common cause pathway between treatment and outcome can remove confounding, whereas adjustment for other structural types may increase bias. For this reason, variable selection would ideally be based on an understanding of the causal network; however, the true causal network is rarely known. Therefore, we describe more practical variable selection approaches based on background knowledge when the causal structure is only partially known. These approaches include adjustment for all observed pretreatment variables thought to have some connection to the outcome, all known risk factors for the outcome, and all direct causes of the treatment or the outcome. Empirical approaches, such as forward and backward selection and automatic high-dimensional proxy adjustment, are also discussed. As there is a continuum between knowing and not knowing the causal, structural relations of variables, we recommend addressing variable selection in a practical way that involves a combination of background knowledge and empirical selection and that uses high-dimensional approaches. This empirical approach can be used to select from a set of a priori variables based on the researcher's knowledge to be included in the final analysis or to identify additional variables for consideration. This more limited use of empirically derived variables may reduce confounding while simultaneously reducing the risk of including variables that may increase bias.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  comparative effectiveness research; covariate selection; pharmacoepidemiology; propensity scores

Mesh:

Year:  2013        PMID: 24006330      PMCID: PMC4190055          DOI: 10.1002/pds.3506

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  34 in total

1.  Data, design, and background knowledge in etiologic inference.

Authors:  J M Robins
Journal:  Epidemiology       Date:  2001-05       Impact factor: 4.822

2.  Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures.

Authors:  Babette A Brumback; Miguel A Hernán; Sebastien J P A Haneuse; James M Robins
Journal:  Stat Med       Date:  2004-03-15       Impact factor: 2.373

3.  Invited commentary: understanding bias amplification.

Authors:  Judea Pearl
Journal:  Am J Epidemiol       Date:  2011-10-27       Impact factor: 4.897

4.  Remarks on the method of propensity score.

Authors:  Judea Pearl
Journal:  Stat Med       Date:  2009-04-30       Impact factor: 2.373

Review 5.  Methodological challenges in causal research on racial and ethnic patterns of cognitive trajectories: measurement, selection, and bias.

Authors:  M Maria Glymour; Jennifer Weuve; Jarvis T Chen
Journal:  Neuropsychol Rev       Date:  2008-09-26       Impact factor: 7.444

6.  Sensitivity analysis: distributional assumptions and confounding assumptions.

Authors:  Tyler J Vanderweele
Journal:  Biometrics       Date:  2008-06       Impact factor: 2.571

7.  Bias formulas for sensitivity analysis of unmeasured confounding for general outcomes, treatments, and confounders.

Authors:  Tyler J Vanderweele; Onyebuchi A Arah
Journal:  Epidemiology       Date:  2011-01       Impact factor: 4.822

8.  Inverse probability-of-censoring weights for the correction of time-varying noncompliance in the effect of randomized highly active antiretroviral therapy on incident AIDS or death.

Authors:  Lauren E Cain; Stephen R Cole
Journal:  Stat Med       Date:  2009-05-30       Impact factor: 2.373

9.  Selective use of calcium channel blockers to treat high-risk hypertensive patients.

Authors:  D M Huse; L H Roht; S C Hartz
Journal:  Pharmacoepidemiol Drug Saf       Date:  2000-01       Impact factor: 2.890

10.  Overadjustment bias and unnecessary adjustment in epidemiologic studies.

Authors:  Enrique F Schisterman; Stephen R Cole; Robert W Platt
Journal:  Epidemiology       Date:  2009-07       Impact factor: 4.822

View more
  35 in total

1.  Urologic care and progression to end-stage kidney disease: a Chronic Kidney Disease in Children (CKiD) nested case-control study.

Authors:  D I Chu; A G Abraham; G E Tasian; M R Denburg; M E Ross; S A Zderic; S L Furth
Journal:  J Pediatr Urol       Date:  2019-03-16       Impact factor: 1.830

2.  Daily hassles, mother-child relationship, and behavior problems in Muslim Arab American adolescents in immigrant families.

Authors:  Karen J Aroian; Thomas N Templin; Edythe S Hough
Journal:  Cultur Divers Ethnic Minor Psychol       Date:  2016-04-07

3.  Diagnostics for Confounding of Time-varying and Other Joint Exposures.

Authors:  John W Jackson
Journal:  Epidemiology       Date:  2016-11       Impact factor: 4.822

4.  Decompositions of the Contribution of Treatment Disparities to Survival Disparities in Stage I-II Pancreatic Adenocarcinoma.

Authors:  Douglas S Swords; Courtney L Scaife
Journal:  Ann Surg Oncol       Date:  2020-11-03       Impact factor: 5.344

5.  Explanation and Elaboration Document for the STROBE-Vet Statement: Strengthening the Reporting of Observational Studies in Epidemiology-Veterinary Extension.

Authors:  A M O'Connor; J M Sargeant; I R Dohoo; H N Erb; M Cevallos; M Egger; A K Ersbøll; S W Martin; L R Nielsen; D L Pearl; D U Pfeiffer; J Sanchez; M E Torrence; H Vigre; C Waldner; M P Ward
Journal:  J Vet Intern Med       Date:  2016-11-07       Impact factor: 3.333

6.  Facility Variation in Local Staging of Rectal Adenocarcinoma and its Contribution to Underutilization of Neoadjuvant Therapy.

Authors:  Douglas S Swords; Benjamin S Brooke; David E Skarda; Gregory J Stoddard; H Tae Kim; William T Sause; Courtney L Scaife
Journal:  J Gastrointest Surg       Date:  2018-11-12       Impact factor: 3.452

7.  Lymph Node Ratio in Pancreatic Adenocarcinoma After Preoperative Chemotherapy vs. Preoperative Chemoradiation and Its Utility in Decisions About Postoperative Chemotherapy.

Authors:  Douglas S Swords; Samual R Francis; Shane Lloyd; Ignacio Garrido-Laguna; Sean J Mulvihill; Joshua D Gruhl; Miles C Christensen; Gregory J Stoddard; Matthew A Firpo; Courtney L Scaife
Journal:  J Gastrointest Surg       Date:  2018-09-05       Impact factor: 3.452

8.  A threshold trajectory was revealed by isolating the effects of hemoglobin rate of rise in anemia of chronic kidney disease.

Authors:  Gregory Fusco; Ali Hariri; Carlos Vallarino; Ajay Singh; Peter Yu; Lesley Wise
Journal:  Ther Adv Drug Saf       Date:  2017-07-12

9.  Propensity Scores in Pharmacoepidemiology: Beyond the Horizon.

Authors:  John W Jackson; Ian Schmid; Elizabeth A Stuart
Journal:  Curr Epidemiol Rep       Date:  2017-11-06

10.  Outcomes of laparoscopic and open surgery in children with and without congenital heart disease.

Authors:  David I Chu; Jonathan M Tan; Peter Mattei; Allan F Simpao; Andrew T Costarino; Aseem R Shukla; Joseph W Rossano; Gregory E Tasian
Journal:  J Pediatr Surg       Date:  2017-11-20       Impact factor: 2.545

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.